STAT
SEPTEMBER 17, 2024
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit on Tuesday demanding that a recent Federal Trade Commission report accusing industry middlemen of raising drug prices be vacated. In scathing language, the company argued the report was “seventy-four pages of unsupported innuendo leveled … under a false and defamatory headline.
PharmaVoice
SEPTEMBER 17, 2024
Big Pharma is embracing the radiopharmaceuticals boom that was a long time in the making.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
SEPTEMBER 17, 2024
Federal health officials wrestling with when and how to use artificial intelligence will on Wednesday host an invitation-only meeting of AI leaders across industry, academia, and government. Called “AI in Action: Transforming Health and Human Services,” the three-hour event is hosted by the federal health department. Its agenda illustrates a department excitedly working through how AI fits into its mission — as well as into the United States’ broader health care syste
BioPharma Dive
SEPTEMBER 17, 2024
Summary study results show Ascendis’ drug for achondroplasia could be competitive to BioMarin's Voxzogo, which is the foundation of the latter company's growth plans.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
STAT
SEPTEMBER 17, 2024
In July, Medicare proposed to start paying for some mental health apps, in a move applauded by the developers of those treatments after years of struggling to find adoption among clinicians and patients. But it wasn’t only the startups and their supporters that took notice — some of the largest pharma and health care companies in the country, like Pfizer and CVS Health, weighed in on the proposal during the comment period, arguing for modifications that suit their vision for how di
pharmaphorum
SEPTEMBER 17, 2024
Apple has the FDA authorisation it needs to bring its software for detecting sleep apnoea to the Apple Watch, coinciding with the launch of its new operating system for the wearable.The Breathing Disturbances function is part of watchOS 11, which makes its debut today alongside the release of the latest Apple Watch Series 10 which was revealed at the company's new product reveal earlier this month and is due to become available on 20th September.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Outsourcing Pharma
SEPTEMBER 17, 2024
One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its candidate olorofim to the market for the treatment of rare fungal infections in 2026.
STAT
SEPTEMBER 17, 2024
Reetam Ganguli once pitched his technology, to rescue women from pregnancy complications, in an airplane bathroom. He often works all night, when other recent college graduates are partying. And he sometimes goes weeks without seeing his girlfriend — or any friend at all. But in the midst of his sacrifices, things are looking up.
BioPharma Dive
SEPTEMBER 17, 2024
The FDA previously rejected patritumab deruxtecan over manufacturing issues. Tuesday's study data should boost the companies' case, however.
STAT
SEPTEMBER 17, 2024
The field of psychedelics, once relegated to the fringes of science and medicine, is in the midst of both transformation and flux. Several key figures stand out in their efforts to push forward the advancement of psychedelic medicine, in the face of ongoing controversy , regulatory hurdles , and stigma. Psychiatric medicine hasn’t seen much innovation in recent decades, even as many say that drugs like psilocybin, MDMA, and DMT can offer real hope to millions of people who suffer from men
Speaker: Joe Sharpe and James Carlson
In the world of small business management, the challenge of managing payroll & HR efficiently while scaling operations can be overwhelming. Yet, with the right strategies in place, these challenges can become opportunities for growth and innovation. In this session, Joe Sharpe, Senior Director of Managed Payroll Services at IRIS, will reveal practical methods and expert insights for outsourcing and streamlining payroll processes, resulting in substantial time and resource savings.
BioPharma Dive
SEPTEMBER 17, 2024
The funding will support mid-stage testing of a drug the company believes to have the potential to treat a range of neurodegenerative conditions.
STAT
SEPTEMBER 17, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I’m in New York this week with my colleague Adam Feuerstein for the Cantor Fitzgerald Healthcare Conference. Say hi if you’re there and you see us!
Outsourcing Pharma
SEPTEMBER 17, 2024
uMotif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its platform with the acquisition of ClinOne, a provider of site platform solutions.
STAT
SEPTEMBER 17, 2024
Top of the morning to you, and a fine one it is, despite the gray skies hovering over the Pharmalot campus. We are doing our best to maintain sunny spirits, though, because once again, we recall some helpful wisdom from the Morning Mayor, who taught us that “every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and inviting you to join us.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
The Pharmacist
SEPTEMBER 17, 2024
Joanna Robertson reports on an exclusive roundtable, held in August this year, which brought together community pharmacy and general practice representatives to discuss the successes, challenges and future of Pharmacy First, six months after the service began in England. Pharmacy First launched in England on 31 January 2024, and sees pharmacists funded to provide advice […] The post Roundtable: Six months of Pharmacy First appeared first on The Pharmacist.
STAT
SEPTEMBER 17, 2024
A U.S. government agency has threatened Johnson & Johnson with sanctions if the company proceeds with plans to alter payment methods for some hospitals that participate in a federal drug discount program. In a letter sent on Tuesday, the U.S. Health Resources and Services Administration maintained that a J&J plan to issue rebates for two widely prescribed medicines instead of offering discounted prices would violate federal law.
The Pharmacist
SEPTEMBER 17, 2024
The government is looking at the negotiations around community pharmacy funding and contractual framework arrangements for 2024/25 'as a matter of urgency', the parliamentary under-secretary for health and social care has said. Responding to a written question from Conservative peer Lord Bourne of Aberystwyth, Baroness Merron noted that the 'consultation with Community Pharmacy England on […] The post Government looking at pharmacy contract 'as matter of urgency' appeared first o
STAT
SEPTEMBER 17, 2024
Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved Kisqali in combination with hormone therapy for patients with certain early-stage breast cancers, significantly expanding the number of patients who will have access to this type of drug.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
pharmaphorum
SEPTEMBER 17, 2024
Boehringer will file its idiopathic pulmonary fibrosis drug nerandolimast next year, a successor to its blockbuster Ofev, after a phase 3 win
Express Pharma
SEPTEMBER 17, 2024
Known as the “Pharmacy of the world”, India is a hub for pharma manufacturing and occupies a hefty 20 per cent share in the global generics volume supply by manufacturing 60,000 different generic brands across 60 therapeutic areas. The industry is poised for considerable growth in the near future and is expected to reach $130 billion by 2030 (currently valued at $50 billion) (1).
pharmaphorum
SEPTEMBER 17, 2024
Mitigating diagnostic errors in clinical trial participants: The role of drug safety/pharmacovigilance Mike.
Pharma Times
SEPTEMBER 17, 2024
The centre aims to discover new drug targets for diseases such as Parkinson’s and hypertension
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
SEPTEMBER 17, 2024
MSD and Daiichi Sankyo's patritumab deruxtecan hit its main objective in a phase 3 lung cancer study that reinforces its potential as a new treatment option for patients after first-line treatment with EGFR inhibitors.The HERTHENA-Lung02 study in EGFR-mutated non-small cell lung cancer (NSCLC), involving patients with locally advanced or metastatic disease previously treated with EGFR drugs, revealed a significant improvement in progression-free survival (PFS) compared to a chemotherapy regimen.
Express Pharma
SEPTEMBER 17, 2024
Novo Nordisk Global Business Services (GBS) announced the launch of a sustainable initiative called Eco Med Safe that aims to promote safe and responsible disposal of pharmaceutical products, on World Patient Safety Day, in partnership with Connect and Heal Foundation. Launched internally for employees, this eco-pharmacovigilance initiative is designed to minimise environmental impact and enhance public health by safely disposing unused or expired medicines.
Drug Patent Watch
SEPTEMBER 17, 2024
Enhancing Your Product Portfolio with CDMOs: A Strategic Partnership for Pharmaceutical Success The pharmaceutical industry is constantly evolving, driven by advancements in technology, innovations in product development, and the need for efficient manufacturing processes.
Express Pharma
SEPTEMBER 17, 2024
Neovantage Innovation Parks has secured its inaugural green loan of Rs 300 crores (~C$ 50 million) from HSBC India. This is HSBC’s first green loan facility in the life sciences real estate sector in India. It was awarded on the back of Neovantage Innovation Parks’ commitment to eco-innovation and sustainable operations across its properties. Neovantage Innovation Parks has achieved this by maintaining all its operating buildings a Gold or higher rating under the LEED for Operations and Maintena
Pharmaceutical Business Review
SEPTEMBER 17, 2024
This collaboration is pivotal as GBS remains a significant cause of severe infections in newborns, accounting for nearly half of all life-threatening cases. With 15-25% of the population, including pregnant individuals, at risk of GBS colonisation, the potential transmission to infants can lead to serious health complications such as sepsis, pneumonia, or meningitis.
PioneerRx
SEPTEMBER 17, 2024
As you well know, there are countless ways to make more money for your pharmacy. From leveraging your pharmacy technology to expanding your clinical services.
pharmaphorum
SEPTEMBER 17, 2024
Boehringer will file its idiopathic pulmonary fibrosis drug nerandolimast next year, a successor to its blockbuster Ofev, after a phase 3 win.
BioPharma Dive
SEPTEMBER 17, 2024
Backed by Bristol Myers Squibb, Ratio Therapeutics has a front row seat to the pharmaceutical industry’s pivot into the field of targeted radiation drugs.
pharmaphorum
SEPTEMBER 17, 2024
Tobacco giant PMI is selling pharma unit Vectura for a fraction of the £1.
Pharmaceutical Technology
SEPTEMBER 17, 2024
Poseida Therapeutics has received RMAT designation from the US FDA for its CAR-T cell therapy, P-BCMA-ALLO1.
Expert insights. Personalized for you.
359 
Let's personalize your content